Literature DB >> 15308358

Vaccine-induced protection against anthrax in cheetah (Acinonyx jubatus) and black rhinoceros (Diceros bicornis).

P C B Turnbull1, B W Tindall, J D Coetzee, C M Conradie, R L Bull, P M Lindeque, O J B Huebschle.   

Abstract

Institution of a policy of vaccination in endangered species with a vaccine not previously administered to it cannot be undertaken lightly. This applies even more in the case of cheetah (Acinonyx jubatus) with their unusually monomorphic gene pool and the potential restrictions this places on their immune responses. However, the recently observed mortalities from anthrax in these animals in the Etosha National Park, Namibia, made it imperative to evaluate vaccination. Black rhinoceros (Diceros bicornis), another endangered species in the park, have been vaccinated for over three decades but the effectiveness of this has never been evaluated. Passive protection tests in A/J mice using sera from 12 cheetahs together with enzyme immunoassay indicated that cheetah are able to mount seemingly normal primary and secondary humoral immune responses to the Sterne 34F2 live spore livestock vaccine. Overall protection rates in mice injected with the sera rose and fell in concert with rises and declines in antibody titres, although fine analysis showed that the correlation between titre and protection was complex. Once a high level of protection (96% of mice 1 month after a second booster in the cheetahs) had been achieved, the duration of substantial protection appeared good (60% of the mice 5 months after the second booster). Protection conferred on mice by sera from three of four vaccinated rhino was almost complete, but, obscurely, none of the mice receiving serum from the fourth rhino were protected. Sera from three park lions with naturally acquired high antibody titres, included as controls, also conferred high levels of protection. For the purposes of wildlife management, the conclusions were that vaccination of cheetah with the standard animal anthrax vaccine causes no observable ill effect in the animals and does appear to confer protective immunity. At least one well-separated booster does appear to be desirable. Vaccination of rhino also appears to be justified from the limited data obtained.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308358     DOI: 10.1016/j.vaccine.2004.02.037

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Authors:  Conrad P Quinn; Carol L Sabourin; Nancy A Niemuth; Han Li; Vera A Semenova; Thomas L Rudge; Heather J Mayfield; Jarad Schiffer; Robert S Mittler; Chris C Ibegbu; Jens Wrammert; Rafi Ahmed; April M Brys; Robert E Hunt; Denyse Levesque; James E Estep; Roy E Barnewall; David M Robinson; Brian D Plikaytis; Nina Marano
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

2.  Anthrax outbreaks in Bangladesh, 2009-2010.

Authors:  Apurba Chakraborty; Salah Uddin Khan; Mohammed Abul Hasnat; Shahana Parveen; M Saiful Islam; Andrea Mikolon; Ranjit Kumar Chakraborty; Be-Nazir Ahmed; Khorsed Ara; Najmul Haider; Sherif R Zaki; Alex R Hoffmaster; Mahmudur Rahman; Stephen P Luby; M Jahangir Hossain
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

Review 3.  Some Peculiarities of Anthrax Epidemiology in Herbivorous and Carnivorous Animals.

Authors:  Irina Bakhteeva; Vitalii Timofeev
Journal:  Life (Basel)       Date:  2022-06-10

4.  Frequent and seasonally variable sublethal anthrax infections are accompanied by short-lived immunity in an endemic system.

Authors:  Carrie A Cizauskas; Steven E Bellan; Wendy C Turner; Russell E Vance; Wayne M Getz
Journal:  J Anim Ecol       Date:  2014-03-14       Impact factor: 5.091

5.  Development of a Sterne-Based Complement Fixation Test to Monitor the Humoral Response Induced by Anthrax Vaccines.

Authors:  Rosanna Adone; Michela Sali; Massimiliano Francia; Michela Iatarola; Adelia Donatiello; Antonio Fasanella
Journal:  Front Microbiol       Date:  2016-01-28       Impact factor: 5.640

6.  Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats.

Authors:  Okechukwu C Ndumnego; Jannie Crafford; Wolfgang Beyer; Henriette van Heerden
Journal:  BMC Vet Res       Date:  2013-12-27       Impact factor: 2.741

7.  Oral vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis Bacillus Calmette-Guerin (BCG).

Authors:  Mitchell V Palmer; Tyler C Thacker; W Ray Waters; Suelee Robbe-Austerman
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

8.  Risk practices for animal and human anthrax in Bangladesh: an exploratory study.

Authors:  Md Saiful Islam; M Jahangir Hossain; Andrea Mikolon; Shahana Parveen; M Salah Uddin Khan; Najmul Haider; Apurba Chakraborty; Abu Mohammad Naser Titu; M Waliur Rahman; Hossain M S Sazzad; Mahmudur Rahman; Emily S Gurley; Stephen P Luby
Journal:  Infect Ecol Epidemiol       Date:  2013-11-27

9.  Use of the mice passive protection test to evaluate the humoral response in goats vaccinated with Sterne 34F2 live spore vaccine.

Authors:  P H Phaswana; O C Ndumnego; S M Koehler; W Beyer; J E Crafford; H van Heerden
Journal:  Vet Res       Date:  2017-09-07       Impact factor: 3.683

10.  The reporting of a Bacillus anthracis B-clade strain in South Africa after more than 20 years.

Authors:  K E Lekota; A Hassim; P Rogers; E H Dekker; R Last; L de Klerk-Lorist; H van Heerden
Journal:  BMC Res Notes       Date:  2018-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.